This company listing is no longer active
Salud financiera de hoja de balance de Biodexa Pharmaceuticals
Salud financiera controles de criterios 4/6
Biodexa Pharmaceuticals has a total shareholder equity of £7.5M and total debt of £0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are £9.7M and £2.2M respectively.
Información clave
0%
Ratio deuda-patrimonio
UK£0
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | UK£6.42m |
| Patrimonio | UK£7.49m |
| Total pasivo | UK£2.19m |
| Activos totales | UK£9.68m |
Actualizaciones recientes sobre salud financiera
Análisis de la situación financiera
Pasivos a corto plazo: BDRX's short term assets (£8.7M) exceed its short term liabilities (£1.6M).
Pasivo a largo plazo: BDRX's short term assets (£8.7M) exceed its long term liabilities (£546.0K).
Historial y análisis de deuda-patrimonio
Nivel de deuda: BDRX is debt free.
Reducción de la deuda: BDRX has no debt compared to 5 years ago when its debt to equity ratio was 4.8%.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: Insufficient data to determine if BDRX has enough cash runway based on its current free cash flow.
Pronóstico de cash runway: Insufficient data to determine if BDRX has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.